Dr. Mamon Y Maiteh MD

Recommended Articles

• Botox May Be a Treatment Option for Migraines

  The National Institute for Health and Clinical Excellence (NICE), has prepared the draft guidance recommending the use of Botox or botulinum toxin type A in the treatment of migraine. According to this guidance, the injections should be stopped if the person has episodic migraine or if the...

• It’s Time to Fight Parkinson’s Disease Through Exercise, Says South Carolina Gym

  Going to the gym regularly can significantly help to combat Parkinson’s disease. According to Cody Cooper from Grit Box Fitness, Parkinson’s progression can be delayed due to the forced intense exercise. Not only that, but it also helps a lot with the enhancing strength and stability.What is...

• Dementia and Why it Happens

  What is dementia?Dementia refers to the loss of brain functions, including memory, thinking, language development and behavior that may affect the daily life of a patient. Many people have slight loss of memory when they are old, but if the memory loss gets worse with time, it indicates dementia....

• What Is a Transient Ischemic Attack (TIA)?

  Transient ischemic attack (TIA) is type of the disease and it drops the blood supply to the brain temporarily. This is due to various reasons. It can make the brain deprive from the oxygen. The person gets stroke which is stroke like situations. Though it does not last long.The transient ischemic...

• A Prolonged Fever of Unknown Origins

  A fever of unknown origins (FUO) is described as febrile disease/illness. It is characterized as the following: A fever greater than 38.3 degree Celsius on several occasions, the duration of the illness lasts for more than 3 weeks, and there is a failure to reach a diagnosis in spite of a weeklong...

• Sarepta Sheds Light on Next Generation Drug for Muscular Dystrophy Patients

  Each company has faced its own set of issues, with Sarepta being one of many that are trying to make amends for some issues that have happened in the past. Although there happened to be some issues with the data that was coming from Sarepta, their approval of the drug that can assist with muscular...